Fin Trust Capital Advisors, LLC Haemonetics Corp Transaction History

Fin Trust Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$80.59 - $92.61 $402 - $463	5 Added 0.85%	595 $50,000
Q3 2023 Oct 24, 2023	SELL	$82.56 - $93.49 $13,127 - $14,864	-159 Reduced 21.23%	590 $52,000
Q2 2023 Jul 25, 2023	SELL	$80.84 - $89.45 $161,680 - $178,900	-2,000 Reduced 72.75%	749 $63,000
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $147,700 - $172,280	2,000 Added 267.02%	2,749 $216,000
Q3 2022 Oct 20, 2022	BUY	$63.3 - $78.66 $47,411 - $58,916	749 New	749 $60,000
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $1,295 - $2,964	-25 Closed	0 $0
Q2 2020 Sep 11, 2020	BUY	$84.96 - $118.91 $2,124 - $2,972	25 New	25 $2,000
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $2,124 - $2,972	-25 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$90.66 - $116.63 $2,266 - $2,915	25 New	25 $3,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.